New antibody AU-007 enters human trials for Hard-to-Treat cancers
NCT ID NCT05267626
First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 27 times
Summary
This study tests a new drug called AU-007 in people with advanced solid tumors that have spread or cannot be removed by surgery. The drug is designed to help the immune system fight cancer. About 159 participants will receive AU-007 alone or with other medicines to find the safest and most effective dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Atlantic Healthcare System
RECRUITINGMorristown, New Jersey, 07960, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Austin Health
RECRUITINGHeidelberg, Victoria, 3084, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Carolina Biooncology Institute
RECRUITINGHuntersville, North Carolina, 28078, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030-4000, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Minnesota Oncology and Hematology PA
RECRUITINGMinneapolis, Minnesota, 55404-4526, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Monash Health
RECRUITINGClayton, Victoria, 3168, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Peninsula & South Eastern Haematology and Oncology Group
RECRUITINGFrankston, Victoria, 3199, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START Midwest
RECRUITINGGrand Rapids, Michigan, 49503-2563, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
START South Texas Accelerated Research Therapeutics
RECRUITINGSan Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203-1619, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southern Oncology Clinical Research Unit
RECRUITINGBedford Park, South Australia, 5042, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Southside Cancer Care Centre
RECRUITINGMiranda, New South Wales, 2228, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sunshine Hospital
RECRUITINGSaint Albans, Victoria, 3021, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sylvester Comprehensive Cancer Center - Miami
RECRUITINGMiami, Florida, 33136-1002, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Texas Oncology (Balcones) - SCRI
RECRUITINGAustin, Texas, 78731-4214, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Utah - Huntsman Cancer Institute
RECRUITINGSalt Lake City, Utah, 84112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Washington University
RECRUITINGSt Louis, Missouri, 63110-1010, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.